Trending Now
DON'T MISS
A new molecular mechanism could explain the origins of the depressive...
About 40 % of the affected patients with Huntington’s disease –a neurodegenerative pathology- show depression symptoms, even in early stages before the apparition of...
My Huntington’s disease sister – and a hero who strives for...
Sharon Shaffer is my Huntington’s disease sister – and my hero.
Afflicted with progressively worse HD symptoms the past 15 years, San Diego area resident...
LATEST VIDEOS
TRAVEL GUIDE
CONVEGNO A RIMINI: LA MALATTIA DI HUNTINGTON. DALLA CLINICA ALLA TERAPIA....
La Neurologia del Presidio ospedaliero Rimini - Santarcangelo - Novafeltria organizza il convegno "La malattia di Huntington. Dalla clinica alla terapia", che si terrà...
Malattia di Huntington, il Governo si impegni a migliorare la conoscenza...
Roma – Per i pazienti affetti da malattia di Huntington e per le loro famiglie buone notizie sul fronte delle politiche socio sanitarie. La risoluzione presentata...
PHONES & DEVICES
Details emerge of first Huntington’s disease gene therapy clinical trial
UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein...
EIP Pharma Initiates New Study with Neflamapimod for the Treatment of...
EIP Pharma, Inc., a CNS-focused therapeutics company, today announced the initiation of a new Phase 2 proof-of-concept study evaluating neflamapimod as a treatment for...
LATEST TRENDS
Nuova sperimentazione del PBT2 prodotto dalla Prana Biotech per la malattia...
Lo studio clinico su BPT2 della Prana Biotech: che sappiamo finora & che ha a che fare il rame con la proteina mutante.
Di Dr...
Zinc Fingers: A New Tool in the Fight Against Huntington’s Disease
Huntington's disease (HD) is an inherited genetic disorder caused by the multiple repetition of a DNA sequence (the nucleotides CAG) in the gene encoding...
TECH
FASHION
REVIEWS
Details emerge of first Huntington’s disease gene therapy clinical trial
UniQure announces key details of its planned trial to assess the safety and ability of AMT-130 gene therapy to lower the problematic huntingtin protein...
ENTERTAIMENT
